February Research Round Up

Every day American Cancer Society researchers and scientists across the world are working to find cancer cures – and better ways to treat and prevent the disease. Below are some of the interesting stories our researchers think you should know about from January.

  • 2014 Cancer Statistics: American Cancer Society researcher, Ahmedin Jemal, D.V.M., Ph.D., discusses the key takeaways from the Society’s three major annual cancer statistics publications.
  • The fight against tobacco, 50 years in: This year marks the 50th anniversary of the landmark Surgeon General’s report linking smoking to lung cancer. Explore how the Society helped establish the link between smoking and cancer, how the anti-tobacco landscape has changed over the decades, and what future efforts are needed.
  • New study on experimental drug idelalisib: Researchers have found that the experimental targeted therapy drug idelalisib may help effectively treat chronic lymphocytic leukemia (CLL) patients without the need for chemotherapy.
  • New way to increase CRC screening rates: American Cancer Society-funded researcher Jennifer Weiss, M.D., with the University of Wisconsin, is working on devising a toolkit that will help health systems nationwide increase their colorectal cancer screening rates.
  • Antioxidant supplements may be harmful: A new study finds that mice given antioxidant supplements developed more and worse lung tumors. This – according to the scientists – means more research is needed to explore the safety of such supplements in people.

To stay up-to-date on the latest cancer research and news, visit and bookmark the Explore Research and News and Features sections of cancer.org.

FOR RESEARCHERS: Learn how to apply for a research grant from the American Cancer Society.

Read more about American Cancer Society researchers.